Home › Trial NCT00004037
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
- Trial IDNCT00004037
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorGynecologic Oncology Group
- Enrollment—
- Start date1998-06
- ConditionsOvarian Cancer · Primary Peritoneal Cavity Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.